The total return over the past 12 months is +42.96% vs. +22.54% for the S&P 500. So far it's up +8.20% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +37.78% | +14.13% | +5.11% | +1.69% | +1.99% | (0.27%) |
| Total Return CAGR | +42.96% | +18.73% | +9.56% | +6.47% | +7.13% | +4.73% |
| Revenue CAGR | +6.68% | +7.85% | +1.38% | +2.05% | +0.16% | +0.43% |
| Net Income CAGR | +42.38% | (28.67%) | (0.41%) | +49.14% | +1.47% | (1.72%) |
| EPS CAGR | +43.38% | +10.55% | (0.71%) | +22.93% | (0.50%) | +0.34% |
| Free Cash Flow CAGR | +51.50% | +43.69% | (2.45%) | +16.01% | +3.94% | +0.28% |
| Operating Cash Flow CAGR | +15.06% | +28.87% | +3.67% | +8.21% | +2.86% | +0.45% |
| Dividends CAGR | +9.10% | +0.34% | (3.77%) | (3.59%) | (1.08%) | +0.53% |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
GSK plc (GSK)
| Year | Start price | End price | GSK Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $49.04 | $52.16 | +8.20% | +13.96% | (5.76%) |
| 2025 | $33.82 | $49.04 | +51.28% | +17.72% | +33.56% |
| 2024 | $37.06 | $33.82 | (5.13%) | +24.89% | (30.02%) |
| 2023 | $35.14 | $37.06 | +9.72% | +26.19% | (16.47%) |
| 2022 | $44.10 | $35.14 | (16.73%) | (18.17%) | +1.44% |
| 2021 | $36.80 | $44.10 | +27.16% | +28.74% | (1.58%) |
| 2020 | $46.99 | $36.80 | (17.64%) | +18.37% | (36.01%) |
| 2019 | $38.21 | $46.99 | +29.28% | +31.22% | (1.94%) |
| 2018 | $35.47 | $38.21 | +13.79% | (4.56%) | +18.35% |
| 2017 | $38.51 | $35.47 | (2.99%) | +21.70% | (24.69%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
